SLN

Silence Therapeutics
SLN

Overview Fund Activity

26 hedge funds and large institutions have $218M invested in Silence Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

Holders
26
Holders Change
+4
Holders Change %
+18.18%
% of All Funds
0.41%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
4
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
LOAME
1
Lombard Odier Asset Management (Europe)
United Kingdom
$29.7M
2
Goldman Sachs
2
Goldman Sachs
New York
$18.4M
3
LOAMU
3
Lombard Odier Asset Management (USA)
New York
$55.7M
4
ACM
4
Altium Capital Management
New York
$2.07M
5
Legal & General Group
5
Legal & General Group
United Kingdom
$288K

Top Sellers

1
FM
1
Frazier Management
Washington
$0
2
CCM
2
Consonance Capital Management
New York
$12.4M
3
CF
3
Cantor Fitzgerald
New York
$3.3M
4
Morgan Stanley
4
Morgan Stanley
New York
$2.88M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
FM
26
Frazier Management
Washington
– – -886,173 Closed
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
– – -6,730 Closed
CSS
28
Cubist Systematic Strategies
Connecticut
– – -184 Closed
TWA
29
TCI Wealth Advisors
Arizona
$0 10 – –
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
1
2